Skip to main content
Log in

Generation of an Induced Pluripotent Stem Cell Line ICGi046-A of a Patient Carrying Pathogenic p.Ser259Thr Variant in RAF1 Associated with RASopathy

  • COLLECTION OF PLURIPOTENT STEM CELL LINES
  • Published:
Russian Journal of Developmental Biology Aims and scope Submit manuscript

Abstract

Technology of generation of induced pluripotent stem cells followed by differentiation into relevant cell type allows obtaining cell models for studying various inherited human diseases. In the study, an induced pluripotent stem cell (iPSC) line (ICGi046-A) was generated as a result of reprogramming of mononuclear cells of a RASopathy patient carrying pathogenic c.775T>A (p.Ser259Thr) variant in RAF1 to the pluripotent state. The ICGi046-A line demonstrated morphology characteristic of human pluripotent cells, normal karyotype (46,XY), expression of pluripotency markers (OCT4, NANOG, SOX2, TRA-1-60), and capacity to give rise to derivatives of three germ layers during spontaneous differentiation. The iPSC line can be used for studying molecular mechanisms of RASopathies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

REFERENCES

  1. Dementyeva, E.V., Pavlova, S.V., Chernyavsky, A.M., and Zakian, S.M., Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3, Stem Cell Res., 2021, vol. 53, p. 102344.

    Article  CAS  PubMed  Google Scholar 

  2. Jaffré, F., Miller, C.L., Schanzer, A., et al., Inducible pluripotent stem cell-derived cardiomyocytes reveal aberrant ERK5 and MEK 1/2 signaling concomitantly promote hypertrophic cardiomyopathy in RAF1-associated Noonan Syndrome, Circulation, 2019, vol. 140, no. 3, pp. 207–224.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Malakhova, A.A., Grigor’eva, E.V., Pavlova, S.V., et al., Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population, Stem Cell Res., 2020, vol. 48, p. 101952.

    Article  CAS  PubMed  Google Scholar 

  4. Melnik, O.V., Gudkova, A.Y., Vershinina, T.L., et al., Clinical polymorphism of RASopathies in terms of the children’s cardiology department, Consilium Medicum, 2017, vol. 19, no. 12, pp. 100–104.

    Article  Google Scholar 

  5. Sorogina, D.A., Grigor’eva, E.V., Malakhova, A.A., et al., Creation of induced pluripotent stem cells ICGi044-B and ICGi044-C using reprogramming of peripheral blood mononuclear cells of a patient with Parkinson’s disease associated with c.1492T>G mutation in the GLUD2 gene, Russ. J. Dev. Biol., 2023, vol. 54, no. 1, pp. 104–111.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

The analysis of karyotype was carried out using the resources of the Common Use Center for Microscopy of Biologic Objects, Siberian Branch, Russian Academy of Sciences, supported by the Budget Project of the Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, FWNR-2022-0015. Equipment of the Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation was used for the analysis of immunofluorescence staining.

Funding

The research was carried out with the financial support of the Russian Science Foundation (project no. 22-15-00271).

Author information

Authors and Affiliations

Authors

Contributions

E.V. Dementyeva, A.A. Kostareva, and S.M. Zakian developed the design of the experiment, analyzed the obtained data, and participated in the writing of the article. E.V. Dementyeva and E.S. Klimenko performed reprogramming of mononuclear cells and characterization of the iPSC line. J.M. Minina analyzed the karyotype of the iPSC line.

Corresponding author

Correspondence to E. V. Dementyeva.

Ethics declarations

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

The study was approved by the Ethics Committee of the Almazov National Medical Research Center of the Ministry of Health of the Russian Federation, protocol no. 01-22-01C dated January 17, 2022. The patient gave voluntary informed consent.

All applicable international, national, and/or institutional principles for the use of animals in experiments and conditions for their care have been observed for obtaining feeder.

Additional information

Passport of the pluripotent stem cell line

Translated by A. S. Ermakov

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dementyeva, E.V., Klimenko, E.S., Minina, J.M. et al. Generation of an Induced Pluripotent Stem Cell Line ICGi046-A of a Patient Carrying Pathogenic p.Ser259Thr Variant in RAF1 Associated with RASopathy. Russ J Dev Biol 54 (Suppl 1), S75–S81 (2023). https://doi.org/10.1134/S1062360423070032

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1062360423070032

Keywords:

Navigation